Maintenance treatment of multiple myeloma-review / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1111-1117, 2009.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-343337
Responsible library:
WPRO
ABSTRACT
Chemotherapy with traditional standard dose or autologous stem cell transplantation (ASCT) after chemotherapy with high dose have some remission effect for multiple myeloma, but relapse still exists. The maintenance treatment would prolonged the remission stage. These treatments included the use of alkylating agent, interferon, corticosteroids, thalidomide and so on. Every maintenance treatment has some advantages and some side effects. The truly effective maintenance treatment would not only minimize the harm of the disease, but also would prolong the overall survival, progression-free survival and the event-free survival. This article summarizes the current progress in the maintenance treatments for multiple myeloma.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Interferons
/
Therapeutic Uses
/
Drug Therapy
/
Alkylating Agents
/
Glucocorticoids
/
Multiple Myeloma
Limits:
Humans
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2009
Document type:
Article